Why Invaio Sciences acquired Peptyde Bio: ‘Peptides represent a major opportunity for biologicals’
Working together, the two teams will be able to speed up development of and access to sustainable crop inputs.
Acquiring Peptyde Bio and its technology “solidifies” Invaio’s bioactive discovery pipeline and platform, says Yajie Niu, Invaio’s Chief Science Officer.
Peptyde’s technology platform discovers, designs, and characterizes novel antimicrobial peptides (AMPs) that could complement or replace traditional chemical fungicides.
“Coupled with our proprietary biological delivery systems — which protect and deliver actives where they’re most needed — we’ll be able to provide growers with crop protection that is both reliable and effective in the field as well as being more sustainable for the environment,” says Niu.